Statistics for Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers
Total visits
views | |
---|---|
Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers | 483 |
Total visits per month
views | |
---|---|
October 2024 | 2 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
1754-1611-6-7.pdf | 319 |
1754-1611-6-7.xml | 173 |
Top country views
views | |
---|---|
United States | 224 |
Germany | 65 |
China | 55 |
Canada | 32 |
Ireland | 18 |
United Kingdom | 6 |
Finland | 4 |
France | 4 |
Vietnam | 3 |
Denmark | 2 |
Russia | 2 |
Singapore | 2 |
Cyprus | 1 |
Estonia | 1 |
Iran | 1 |
Norway | 1 |
Taiwan | 1 |
South Africa | 1 |
Top city views
views | |
---|---|
Ashburn | 176 |
Beijing | 52 |
Winnipeg | 28 |
Dublin | 16 |
Inglewood | 8 |
Des Moines | 4 |
Leipzig | 4 |
Mountain View | 4 |
Munich | 4 |
Oldenburg | 4 |
Palo Alto | 4 |
Saint Robert | 4 |
Hanoi | 3 |
Nürnberg | 3 |
Brooklyn | 2 |
Burlington | 2 |
Burton-on-Trent | 2 |
Copenhagen | 2 |
Helsinki | 2 |
Landshut | 2 |
Leeds | 2 |
Los Angeles | 2 |
Offenburg | 2 |
Seattle | 2 |
Zhengzhou | 2 |
Boardman | 1 |
Frankfurt am Main | 1 |
Heidelberg | 1 |
Johannesburg | 1 |
Mannheim | 1 |
Morlenbach | 1 |
Moscow | 1 |
Mudau | 1 |
Nagold | 1 |
Ottawa | 1 |
Phoenix | 1 |
Shenyang | 1 |
Singapore | 1 |
Taichung | 1 |
Toronto | 1 |